MULTIDISCIPLINARY GENITOURINARY ONCOLOGY COURSE
|
|
- Katherine Warner
- 5 years ago
- Views:
Transcription
1 MULTIDISCIPLINARY GENITOURINARY ONCOLOGY COURSE Case 2 Testicular Cancer Nuno Sineiro Vau Medical Oncologist Champalimaud Foundation, Lisbon October 2017
2 Male, 36 year-old, sales manager. Past medical history NKDA. Smoker. No drinking habits. Migraine. No family history of oncological diseases. Medication Morphine. Acetaminophen. Alprazolam.
3 Aug 14 Backache Sep 14 Worsening backache. Unremarkable blood tests (decreasing MCV: fl). Thoracic and lumbar spine CT scan unremarkable. Oct 14 Testicular swelling and pain. LDH 1755 U/L; AFP 14 ng/ml and hcg miu/l. Testicular ultrasound: Suspicious right testicular nodule.
4 Oct 14 (Cont.) Nov 14 TAP CT: Multiple lung metastasis; multiple enlarged thoracic lymph nodes; multiple liver metastasis; massive retroperitoneal lymph node conglomerate (12,8 x 11,7 x 8,2 cm), compressed inferior VC. Backache, asthenia and headache. PS0. PE: Epigastric mass. Analgesia adjustment. Started LMWH. Refused sperm preservation. Lung function tests normal. Brain MRI normal
5 Nov 14 (Cont.) Surgery: right orchiectomy. Histology: Mixed germ cell tumour ( Choriocarcinoma 70%; Seminoma 30%); 3.3 cm; V1; rete testis invasion. Without invasion of spermatic cord, tunica albuginea nor tunica vaginalis. LDH 1971 U/L; AFP 16 ng/ml and hcg miu/l. Hg 7,9 g/dl; ALP 255 U/L; TGO 48 U/L; TGP 60 U/L; GT 212 U/L; Total Bili 3,3 mg/dl. Staging: IIIC (pt2cn3m1bs3) poor risk (IGCCCG).
6 Nov 14 (Cont.) Started chemotherapy BEP (75% VP16). During C1 admitted due to fatigue G3, anaemia G3, neutropenia G3, Pharyngitis G2. Backache remission. Decreasing epigastric mass. Increasing (CT scan) liver and nodal metastasis. C1d21: LDH 1031 U/L and hcg miu/l Unfavourable TTN (Fizazi K et al. J Clin Oncol 2004). Started BEP C2 (100% VP16). During C2 admitted due to fatigue G3 and pancytopenia.
7 Dec 14 C2d28 LDH 851 U/L and hcg 2575 miu/l. Dose intensification GETUG 13 (Fizazi K et al. Lancet Oncol 2014). Started C1 P-BEP-OXA + G (Paclitaxel 175 mg/m2 d1 before BEP plus Oxaliplatin 130 mg/m2 day 10). C3d7 Admitted febrile neutropenia G4. Generalized oedema. Pharyngitis G3. Anemia G2. Thrombocytopenia G3. Hypoalbuminemia G3. Anorexia G3. Weight loss G2. PS 2-3. C3d8 Christmas Miracle. C3d10 Omitted Oxaliplatin.
8 Jan 15 C3d28 LDH 364 U/L and hcg 246 miu/l. C3d35 Paresthesia G3. Stopped dose intensification strategy. Started BEP C4 (PEG and prophylactic Ciprofloxacin and Fluconazole). C4d9 Admitted. Worsening fatigue G3. Anemia G3. Hyponatremia G3.
9 Mar 15 Paresthesia G3. Fatigue G2. Prolonged hyponatremia. LDH 217 U/L, AFP 9,9 ng/ml and hcg 3,4 miu/l. TAP CT (PR): Lung PR (biggest 17 8 mm). ccr thoracic lymph nodes. Liver PR (biggest 8,5 4 cm). Major abdominal lymph nodes PR (12 2,8 cm). Apr 15 LDH 250 U/L, AFP 6,8 ng/ml and hcg 3,1 miu/l. PET -TAC FDG: Increased uptake in multiple liver metastasis, in a retroperitoneal lymph node and in a lung metastasis
10
11 Apr 15 (Cont) Referred for HDC-ASCT. Jun 15 Surgery: Liver biopsy. Retroperitoneal lymphadenectomy. Pulmonary nodule resection. Histology: All 3 samples without viable neoplastic tissue.
12 Jul 15 Paresthesia G3. Fatigue G1. PS1. LDH 254 U/L, AFP 5 ng/ml and hcg 2,34 miu/l. PET -TAC FDG: Increased uptake in multiple liver metastasis and de novo in retroperitoneal and pelvic lymph nodes. Lung uptake attributed to prior surgery.
13 Set 15 Paresthesia G2-3. PS1. LDH 332 U/L, AFP 4,9 ng/ml and hcg 2,5 miu/l. W&W Oct 15 Paresthesia G2-3. PS1. LDH 354 U/L, AFP 7,2 ng/ml and hcg 2,2 miu/l. TAP CT: Lung alterations due to prior surgery. Stable hepatic metastasis ( central necrosis). Multiple small retroperitoneal lymph nodes. W&W
14 Dec 15 to present date Last appointment 4 days ago. Paresthesia G2-3. Retired. Depression. PS1. Without biochemical progression. Serial CT scan (last one this week) with stable liver lesions. Without other evidence of disease W&W
15
16 Fizazi K et al. Early Predicted Time to Normalization of Tumor Markers Predicts Outcome in Poor-Prognosis Nonseminomatous Germ Cell Tumors. J Clin Oncol Evaluate the prognostic relevance of the rate of decline of serum alphafetoprotein (AFP) and human chorionic gonadotropin (HCG) during the first 3 weeks of chemotherapy. N= 653. Decline rates were calculated using a logarithmic formula and expressed as a predicted time to normalization (TTN) TTN was associated with both PFS (P <0.0001) and OS (P<0.0001). OS4y were 83% and 58%. This effect was independent from the initial S, the primary tumor site, and the presence of nonpulmonary visceral metastases PF S OS
17 Fizazi K et al. Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial. Lancet Oncol Assess whether treatment intensification based on an early tumour marker decline will improve PFS in IGCCCG poor risk. BEP1 HCG and AFP measured d18-21: Favourable TTN 3xBEP Unfavourable TTN Randomization: 3xBEP vs. Dose-dense [(P 175 d1 + BEP + OXA 130 d10) x2 (DDP 100 d1 + IFF 2 d10,12 and 14 + Bleo 25U qd d10 to 14)x2] + G. n= % favourable TTN and 80% unfavourable TTN. PFSV3y: 59% Unfav-dose-dense vs. 48% Unfav-BEP vs. 70% Fav-BEP. More G34 neurotoxicity (7% vs 1%) and more haematotoxicity; BUT no difference in FN (17% vs 18) or toxic deaths (1% in both groups). Salvage HDCT plus stem-cell transplant in 6% Unfav-dose-dense vs. 16% in Unfav-BEP.
18 Treglia G et al. Diagnostic performance of fluorine-18- fluorodeoxyglucose positron emission tomography in the postchemotherapy management of patients with seminoma: systematic review and meta-analysis. Biomed Res Int 2014;2014. Pooled analysis demonstrated a sensitivity of 78%, a specificity of 86%, PPV of 58%, NPV of 94%, and accuracy of 84%. A better diagnostic accuracy of FDG PET or PET/CT in evaluating residual or recurrent lesions greater than 3 cm compared with those less than 3 cm. Oechsle K et al. [18F] Fluorodeoxyglucose positron emission tomography in nonseminomatous germ cell tumors after chemo- therapy: the German multicenter positron emission tomography study group. J Clin Oncol Prospective study. Evaluates the accuracy of FDG PET in NSGCT for the prediction of histology compared with CT and serum tumor markers. n=121. Pts with IIC or III NSGCT scheduled for resection after DDP-based CT. FDG PET performed after CT. Prediction of tumor viability with FDG PET was correct in 56%. It was not better than the accuracy of CT (55%) or serum tumor markers (56%). Sensitivity and specificity of FDG PET were 70% and 48%. PPV were not different (55%, 61%, and 59% for CT, STM and PET, respectively). In NSGCT, FDG-PET is less helpful in predicting histology in residual masses after chemotherapy than in patients with pure seminoma.
Germ Cell Tumors. Karim Fizazi, MD, PhD Institut Gustave Roussy, France
Germ Cell Tumors Karim Fizazi, MD, PhD Institut Gustave Roussy, France Surveillance for stage I GCT NSGCT A 26 year-old patient had a orchiectomy revealing embryonal carcinoma (40%), seminoma (40%) and
More informationQuiz 1. Assign Race 1, Race 2 and Spanish Hispanic Origin to the following scenarios.
Quiz 1 Assign Race 1, Race 2 and Spanish Hispanic Origin to the following scenarios. 1. 62 year old Brazilian female Race 1 Race 2 Spanish/Hispanic Origin 2. 43 year old Asian male born in Japan Race 1
More informationPoor-prognostic advanced Germ Cell Tumors
14-10-16 Poor-prognostic advanced Germ Cell Tumors Karim Fizazi, MD, PhD Institut Gustave Roussy, France Metastatic GCT: Prognosis (IGCCC) Good prognosis Intermediate prognosis Poor prognosis J Clin Oncol
More informationNICaN Testicular Germ Cell Tumours SACT protocols
Reference No: Title: Author(s) Ownership: Approval by: Systemic Anti-Cancer Therapy (SACT) Guidelines for Germ Cell Tumours Dr Audrey Fenton Consultant Medical Oncologist, Dr Vicky Coyle Consultant Medical
More informationGUIDELINES ON TESTICULAR CANCER
38 (Text updated March 2005) P. Albers (chairman), W. Albrecht, F. Algaba, C. Bokemeyer, G. Cohn-Cedermark, A. Horwich, O. Klepp, M.P. Laguna, G. Pizzocaro Introduction Compared with other types of cancer
More informationEAU GUIDELINES ON TESTICULAR CANCER
EAU GUIDELINES ON TESTICULAR CANCER (Limited text update March 2015) P. Albers (Chair), W. Albrecht, F. Algaba, C. Bokemeyer, G. Cohn-Cedermark, K. Fizazi, A. Horwich, M.P. Laguna, N. Nicolai, J. Oldenburg
More informationTesticular Cancer. J. Richard Auman, MD. James J. Stark, MD. Jerry Singer, MD. September 19, 2008
Testicular Cancer J. Richard Auman, MD James J. Stark, MD Jerry Singer, MD September 19, 2008 Testicular Cancer From mystery to far-advanced disease: a remarkable case Case Presentation. 23 y. o. male
More informationCase Scenario 1 Discharge Summary Pathology Report Final Diagnosis: Oncology Consult
Case Scenario 1 Discharge Summary A 31-year-old Brazilian male presented with a 6 month history of right-sided scrotal swelling. Backache was present for 2 months and a history of right epididymitis was
More informationCase Scenario 1 Discharge Summary Pathology Report Final Diagnosis: Oncology Consult
Case Scenario 1 Discharge Summary A 31-year-old Brazilian male presented with a 6 month history of right-sided scrotal swelling. Backache was present for 2 months and a history of right epididymitis was
More informationEAU GUIDELINES ON TESTICULAR CANCER
EAU GUIDELINES ON TESTICULAR CANCER (Limited text update March 2018) P. Albers (Chair), W. Albrecht, F. Algaba, C. Bokemeyer, G. Cohn-Cedermark, K. Fizazi, A. Horwich, M.P. Laguna (Vice-chair), N. Nicolai,
More informationTESTICULAR CANCER Updated March 2016 by Dr. Safiya Karim (PGY-5 Medical Oncology Resident, University of Toronto)
TESTICULAR CANCER Updated March 2016 by Dr. Safiya Karim (PGY-5 Medical Oncology Resident, University of Toronto) Reviewed by Dr. Aaron Hansen (Staff Medical Oncologist, University of Toronto) DISCLAIMER:
More informationExercise. Discharge Summary
Exercise Discharge Summary A 32-year-old Brazilian male presented with a 6 month history of right-sided scrotal swelling. Backache was present for 2 months and a history of right epididymitis was present
More informationEAU GUIDELINES ON TESTICULAR CANCER
EU GUIDELINES ON TESTICULR CNCER (Limited text update March 2017) P. lbers (Chair), W. lbrecht, F. lgaba, C. Bokemeyer, G. Cohn-Cedermark, K. Fizazi,. Horwich, M.P. Laguna, N. Nicolai, J. Oldenburg Introduction
More informationSTAGING AND FOLLOW-UP STRATEGIES
ATHENS 4-6 October 2018 European Society of Urogenital Radiology STAGING AND FOLLOW-UP STRATEGIES Ahmet Tuncay Turgut, MD Professor of Radiology Hacettepe University, Faculty of Medicine Ankara 2nd ESUR
More informationASYMPTOMATIC COMPLEX TESTICULAR NEOPLASIA ASSOCIATED WITH ORCHIEPIDIDYMITIS. CASE REPORT
Rev. Med. Chir. Soc. Med. Nat., Iaşi 2017 vol. 121, no. 4 SURGERY CASE REPORTS ASYMPTOMATIC COMPLEX TESTICULAR NEOPLASIA ASSOCIATED WITH ORCHIEPIDIDYMITIS. CASE REPORT Ș. Iacob 1, R. Vrînceanu 2,3, B.
More informationUK CAA Oncology Certification Charts
UK CAA Oncology Certification Charts 1. Colorectal 2. Malignant Melanoma 3. Germ Cell Tumour of Testis 4. Renal Cell Carcinoma 5. Breast Carcinoma 6. Non-small Cell Lung Cancer Note: All Class 1 cases
More informationDoppler ultrasound of the abdomen and pelvis, and color Doppler
- - - - - - - - - - - - - Testicular tumors are rare in children. They account for only 1% of all pediatric solid tumors and 3% of all testicular tumors [1,2]. The annual incidence of testicular tumors
More informationESMO Consensus Empfehlungen 2017
ESMO Consensus Empfehlungen 2017 What s old, what s new, what s missing? Jörg Beyer, Klinik für Onkologie Offenlegung Interessenskonflikte 1. Anstellungsverhältnis oder Führungsposition Keine 2. Beratungs-
More informationThe Use of PET Scanning in Urologic Oncology
The Use of PET Scanning in Urologic Oncology Dr Nicholas C. Buchan Uro-oncology Fellow 1 2 Aims To understand the basic concepts underlying PET scanning. Understand the emerging role of PET Scanning for
More informationTesticular Malignancies /8/15
Collecting Cancer Data: Testis 2014-2015 NAACCR Webinar Series January 8, 2015 Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants watching
More informationLate recurrence of an embryonal carcinoma of the testis. Case report
Late recurrence of an embryonal carcinoma of the testis. Case report Luminita Gurguta 1 *, Mihai V. Marinca 1, 2 1 Medical Oncology Department, Regional Institute of Oncology, Iasi, Romania, 2 Department,
More informationResection of retroperitoneal residual mass after chemotherapy in patients with nonseminomatous testicular cancer
Turkish Journal of Cancer Vol.31/ No. 2/2001 Resection of retroperitoneal residual mass after chemotherapy in patients with nonseminomatous testicular cancer AHMET ÖZET 1, ALİ AYDIN YAVUZ 1, MURAT BEYZADEOĞLU
More informationFellow GU Lecture Series, Testicular Cancer. Asit Paul, MD, PhD 02/06/2018
Fellow GU Lecture Series, 2018 Testicular Cancer Asit Paul, MD, PhD 02/06/2018 Rare cancer worldwide, approximately 1% of all male cancers There is a large difference among ethnic/racial groups. Rates
More informationANZUP SURVEILLANCE RECOMMENDATIONS FOR METASTATIC TESTICULAR CANCER POST-CHEMOTHERAPY
ANZUP SURVEILLANCE RECOMMENDATIONS FOR METASTATIC TESTICULAR CANCER POST-CHEMOTHERAPY Note: These surveillance recommendations are provided as recommendations only. Clinicians should take into account
More informationCorporate Medical Policy
Corporate Medical Policy Hematopoietic Stem-Cell Transplantation in the Treatment of Germ File Name: Origination: Last CAP Review: Next CAP Review: Last Review: hematopoietic_stem-cell_transplantation_in_the_treatment_of_germ_cell_tumor
More informationFellow GU Lecture Series, Testicular Cancer. Asit Paul, MD, PhD 02/06/2018
Fellow GU Lecture Series, 2018 Testicular Cancer Asit Paul, MD, PhD 02/06/2018 Rare cancer worldwide, approximately 1% of all male cancers There is a large difference among ethnic/racial groups. Rates
More informationPopulations Interventions Comparators Outcomes Individuals: With previously untreated germ cell tumors
Hematopoietic Cell Transplantation in the Treatment of Germ Cell (80135) (Formerly Hematopoietic Stem Cell Transplantation in the Treatment of Germ Cell ) Medical Benefit Effective Date: 04/01/13 Next
More informationTesticular Cancer. Prof. Dr. Jörg Beyer Physician-in-Chief Department of Oncology, University Hospital Berne, Switzerland. Mail:
Testicular Cancer Prof. Dr. Jörg Beyer Physician-in-Chief Department of Oncology, University Hospital Berne, Switzerland Mail: joerg.beyer@insel.ch The menue: Epidemiology & Staging Ongoing discussions
More informationTesticular germ cell tumors
Testicular germ cell tumors Introduction Most common solid tumor in young adult men with 3 6 new cases/100,000 men/year. They acc ount for 1.5% of male malignancies and 5% of urological tumors. Bilateral
More informationTestis. Protocol applies to all malignant germ cell and malignant sex cord-stromal tumors of the testis, exclusive of paratesticular malignancies.
Testis Protocol applies to all malignant germ cell and malignant sex cord-stromal tumors of the testis, exclusive of paratesticular malignancies. Protocol revision date: January 2005 Based on AJCC/UICC
More informationTesticular cancer and other germ cell tumours. London Cancer Jonathan Shamash
Testicular cancer and other germ cell tumours London Cancer 2018 Jonathan Shamash Background Testicular germ cell tumours are the commonest cancers of young men Overall they are curable but long term side
More informationGUIDELINES ON TESTICULAR CANCER
European Association of Urology GUIDELINES ON TESTICULAR CANCER P. Albers (chairman), W. Albrecht, F. Algaba, C. Bokemeyer, G. Cohn-Cedermark, A. Horwich, O. Klepp, M.P. Laguna, G. Pizzocaro UPDATE MARCH
More informationDr Sneha Shah Tata Memorial Hospital, Mumbai.
Dr Sneha Shah Tata Memorial Hospital, Mumbai. Topics covered Lymphomas including Burkitts Pediatric solid tumors (non CNS) Musculoskeletal Ewings & osteosarcoma. Neuroblastomas Nasopharyngeal carcinomas
More informationUncommon secondary tumour of the stomach
Uncommon secondary tumour of the stomach B. Bancel, Hôpital CROIX ROUSSE LYON Bucharest Nov 2013 Case report 33-year old man Profound mental retardation and motor disturbances (sequelae of neonatal meningeal
More informationWhen to Integrate Surgery for Metatstatic Urothelial Cancers
When to Integrate Surgery for Metatstatic Urothelial Cancers Wade J. Sexton, M.D. Senior Member and Professor Department of Genitourinary Oncology Moffitt Cancer Center Case Presentation #1 67 yo male
More informationGERM-CELL TUMOURS. ESMO Preceptorship on Adolescents and Young Adults with cancer Lugano, May 2018
ESMO Preceptorship on Adolescents and Young Adults with cancer Lugano, 11-12 May 2018 GERM-CELL TUMOURS Giannis Mountzios MSc, PhD Medical Oncology University of Athens School of Medicine Athens, Greece
More informationGuidelines on Testicular Cancer
Guidelines on Testicular Cancer P. Albers (chairman), W. Albrecht, F. Algaba, C. Bokemeyer, G. Cohn-Cedermark, K. Fizazi, A. Horwich, M.P. Laguna European Association of Urology 2009 TABLE OF CONTENTS
More informationTestis tumors. Richard Epstein
Testis tumors Richard Epstein TKCC/SVH, August 5 2016 Testis cancer - Remains virtually the only solid (nonhaematologic) metastatic tumour that is routinely curable by drug therapy. What we will discuss
More informationCardiff MRCS OSCE Courses Testicular Cancer
Testicular Cancer Scenario: A 40-year-old male presents to the surgical out-patient clinic with a 6-8 week history of a painless lump in his left scrotum. He however complains of a dull ache in the scrotum
More informationPET/CT in lung cancer
PET/CT in lung cancer Andrei Šamarin North Estonia Medical Centre 3 rd Baltic Congress of Radiology 08.10.2010 Imaging in lung cancer Why do we need PET/CT? CT is routine imaging modality for staging of
More informationRegressed Testicular Seminoma with Extensive Metastases. S Andhavarapu, B Low, J Raj, S Skinner, J Armenta-Corona
ISPUB.COM The Internet Journal of Oncology Volume 5 Number 1 S Andhavarapu, B Low, J Raj, S Skinner, J Armenta-Corona Citation S Andhavarapu, B Low, J Raj, S Skinner, J Armenta-Corona.. The Internet Journal
More informationCitation for published version (APA): Lutke Holzik, M. F. (2007). Genetic predisposition to testicular cancer s.n.
University of Groningen Genetic predisposition to testicular cancer Lutke Holzik, Martijn Frederik IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite
More informationCase Report Seminoma Presenting as Renal Mass, Inferior Vena Caval Thrombus, and Regressed Testicular Mass
Case Reports in Urology Volume 2015, Article ID 835962, 4 pages http://dx.doi.org/10.1155/2015/835962 Case Report Seminoma Presenting as Renal Mass, Inferior Vena Caval Thrombus, and Regressed Testicular
More informationProstate Case Scenario 1
Prostate Case Scenario 1 H&P 5/12/16: A 57-year-old Hispanic male presents with frequency of micturition, urinary urgency, and hesitancy associated with a weak stream. Over the past several weeks, he has
More informationPage 1 of 17 TABLE OF CONTENTS
Page 1 of 17 TABLE OF CONTENTS Suspicious Testicular Cancer. Page 2 nseminomatous Germ Cell Tumor (NSGCT): workup and clinical stage Page 3 Seminoma: workup and clinical stage... Page 4 Clinical Stage
More informationRunning Title: Utility of HCG Washout in Cervical LND FNA
AACE Clinical Case Reports Rapid Electronic Articles in Press Rapid Electronic Articles in Press are preprinted manuscripts that have been reviewed and accepted for publication, but have yet to be edited,
More informationFDG-PET/CT in Gynaecologic Cancers
Friday, August 31, 2012 Session 6, 9:00-9:30 FDG-PET/CT in Gynaecologic Cancers (Uterine) cervical cancer Endometrial cancer & Uterine sarcomas Ovarian cancer Little mermaid (Edvard Eriksen 1913) honoring
More informationLong-Term Outcome for Men With Teratoma Found at Postchemotherapy Retroperitoneal Lymph Node Dissection
Original Article Long-Term Outcome for Men With Teratoma Found at Postchemotherapy Retroperitoneal Lymph Node Dissection Robert S. Svatek, MD 1, Philippe E. Spiess, MD 2, Debasish Sundi, BS 1, Shi-ming
More informationA Case of Metastatic Lung Adenocarcinoma EGFR ve, ALK +
ESMO Preceptorship Programme Dr Najihah Abu Bakar University Malaya Medical Centre, Kuala Lumpur, Malaysia A Case of Metastatic Lung Adenocarcinoma EGFR ve, ALK + HISTORY Mr TT/ 65yo/ Male/ Non smoker/no
More informationViable Germ Cell Tumor at Postchemotherapy Retroperitoneal Lymph Node Dissection. Can We Predict Patients at Risk of Disease Progression?
2700 Viable Germ Cell Tumor at Postchemotherapy Retroperitoneal Lymph Node Dissection Can We Predict Patients at Risk of Disease Progression? Philippe E. Spiess, MD 1 Nizar M. Tannir, MD 2 Shi-Ming Tu,
More informationTeratocarcinoma In A Young Boy- An Unusual Presentation
Human Journals Case Report November 2015 Vol.:2, Issue:1 All rights are reserved by Atia Zaka-ur-Rab et al. Teratocarcinoma In A Young Boy- An Unusual Presentation Keywords: Boy, Testicular Mass, Teratocarcinoma
More informationInterim PET Hodgkin s Disease. Fellows talk Fellow: Shweta Jain Faculty: Ajay Gopal
Interim PET Hodgkin s Disease Fellows talk Fellow: Shweta Jain Faculty: Ajay Gopal Why is this a Question? Early Advanced ipet ABVD + RT ABVD Pos Neg ABVD Beacopp Escalation Salvage Deescalation Talk outline
More informationMetastasis of Testicular Carcinoma in The Inguinal Region
CASE REPORT Agus Rizal AH Hamid, Rainy Umbas Department of Urology, Faculty of Medicine, University of Indonesia - dr. Cipto Mangunkusumo Hospital. Jl. Diponegoro no. 71, Jakarta Pusat. Correspondence
More informationWhat is Testicular cancer?
Testicular Cancer What is Testicular cancer? Testicular cancer is a disease in which cancer cells form in the tissues of one or both testicles. The testicles are 2 egg-shaped glands located inside the
More informationManagement of Stage Ic-IV Malignant Ovarian Germ Cell Tumours
Management of Stage Ic-IV Malignant Ovarian Germ Cell Tumours Michael J Seckl Charing Cross Hospital Campus of Imperial College NHS Healthcare Trust Imperial College London, UK 9-12th June 2010 Caravaggio
More informationMixed Germ Cell Testis Tumor Presenting with Massive Lung Metastasis
International Archives of Medical Research Volume 10, No.1, pp.21-26, 2018. CASE REPORT RESEARCH Mixed Germ Cell Testis Tumor Presenting with Massive Lung Metastasis Zuhat Urakci 1, Senar Ebinc 1, Ogur
More informationTESTICULAR CANCER has been one of the major success
Intensive Induction Chemotherapy With CBOP/BEP in Patients With Poor Prognosis Germ Cell Tumors By J.A. Christian, R.A. Huddart, A. Norman, M. Mason, S. Fossa, N. Aass, E.J. Nicholl, D.P. Dearnaley, and
More informationTitle Late recurrence of nonseminomatous successfully treated with intensity Author(s) Kita, Yuki; Imamura, Masaaki; Mizow Yoshiki; Yoshimura, Koji; Hiraoka, Citation Japanese journal of clinical oncolo
More informationChemotherapy for Urological Cancers
Chemotherapy for Urologic Cancers Matthew Rettig, MD Associate Professor Department of Medicine Division of Hematology-Oncology Department of Urology Medical Director, Prostate Cancer Program Institute
More information-The cause of testicular neoplasms remains unknown
- In the 15- to 34-year-old age group, they are the most common tumors of men. - include: I. Germ cell tumors : (95%); all are malignant. II. Sex cord-stromal tumors: from Sertoli or Leydig cells; usually
More informationPRO STATE of the art. METASTATIC HORMONE SENSITIVE PROSTATE CANCER Clinical case and evidences from literature
PRO STATE of the art METASTATIC HORMONE SENSITIVE PROSTATE CANCER Clinical case and evidences from literature Marcello Tucci, MD Department of Oncology San Luigi Gonzaga Hospital Orbassano, Turin 30 MAY
More informationPET-imaging: when can it be used to direct lymphoma treatment?
PET-imaging: when can it be used to direct lymphoma treatment? Luca Ceriani Nuclear Medicine and PET-CT centre Oncology Institute of Southern Switzerland Bellinzona Disclosure slide I declare no conflict
More informationGUIDELINES FOR THE MANAGEMENT OF UROLOGICAL CANCER
GUIDELINES FOR THE MANAGEMENT OF UROLOGICAL CANCER Testicular Tumour Treatment Guidelines Authors: Professor Peter Clark Mr Mark Fordham Review Date: May 2017 CONTENTS Page 1. Introduction 4 2. Details
More informationmolecular brothers David Pfisterer Lucerne, Switzerland ESIM 2011
molecular brothers David Pfisterer Lucerne, Switzerland ESIM 2011 Case Vignette A 25-year old man was admitted to our hospital because of fever, productive cough, nausea and weight loss. The patient had
More informationRECTAL CANCER CLINICAL CASE PRESENTATION
RECTAL CANCER CLINICAL CASE PRESENTATION Francesco Sclafani Medical Oncologist, Clinical Research Fellow The Royal Marsden NHS Foundation Trust, London, UK esmo.org Disclosure I have nothing to declare
More informationTesticular Cancer. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ) Version December 8, NCCN.org.
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ) Version 2.2017 December 8, 2016 NCCN.org Continue Version 2.2017, 12/08/16 National Comprehensive Cancer Network, Inc. 2016, All rights
More informationNew Visions in PET: Surgical Decision Making and PET/CT
New Visions in PET: Surgical Decision Making and PET/CT Stanley J. Goldsmith, MD Director, Nuclear Medicine Professor, Radiology & Medicine New York Presbyterian Hospital- Weill Cornell Medical Center
More informationStrategies for the Treatment of Elderly DLBCL Patients, New Combination Therapy in NHL, and Maintenance Rituximab Therapy in FL
New Evidence reports on presentations given at ASH 2009 Strategies for the Treatment of Elderly DLBCL Patients, New Combination Therapy in NHL, and Maintenance Rituximab Therapy in FL From ASH 2009: Non-Hodgkin
More informationNerve-sparing retroperitoneal lymph node dissection for advanced testicular cancer after chemotherapy
Blackwell Science, LtdOxford, UK IJU International Journal of Urology 0919-81722002 Blackwell Science Asia Pty Ltd 910October 2002 520 Postchemotherapy nerve-sparing RPLND N Nonomura et al. 10.1046/j.0919-8172.2002.00520.x
More informationCollecting Cancer Data: Testis 2/3/11. Collecting Cancer Data: NAACCR Webinar Series 1. Agenda. Fabulous Prizes
Collecting Cancer Data: Testis February 3, 2011 NAACCR 2010-2011 Webinar Series Agenda Coding moment Race/Hispanic origin Overview Collaborative Stage Treatment Exercises Fabulous Prizes NAACCR 2010-2011
More informationGerm cell tumors (GCT) are uncommon neoplasms
ORIGINAL ARTICLES: GENERAL THORACIC Pulmonary Metastasectomy for Testicular Germ Cell Tumors: A 28-Year Experience David Liu, MD, Amir Abolhoda, MD, Michael E. Burt, MD, PhD, Nael Martini, MD, Manjit S.
More informationMale Genital Cancers in the US in Frequency of Types
Germ Cell Tumors of the Testis Pathology, Immunohistochemistry, and the Often Confusing Appearance of Their Metastases Charles Zaloudek, MD Department of Pathology UCSF Male Genital Cancers in the US in
More informationNote: The cause of testicular neoplasms remains unknown
- In the 15- to 34-year-old age group, they are the most common tumors of men. - Tumors of the testis are a heterogeneous group of neoplasms that include: I. Germ cell tumors : 95%; all are malignant.
More informationMaria João Cardoso, MD, PhD
Locally Advanced Breast Cancer Specific Issues in LocorregionalTreatment Surgery, MD, PhD Head Breast Surgeon Breast Unit, Champalimaud Foundation Lisbon, Portugal 1 Conflict of Interest Disclosure No
More informationCase Report Primary Malignancy in a Supernumerary Testicle Presenting as a Large Pelvic Mass
Hindawi Volume 2017, Article ID 4529853, 4 pages https://doi.org/10.1155/2017/4529853 Case Report Primary Malignancy in a Supernumerary Testicle Presenting as a Large Pelvic Mass Justin Noroozian, 1 Daniel
More informationCurrent role of chemotherapy in hormone-naïve patients Elena Castro
Current role of chemotherapy in hormone-naïve patients Elena Castro Spanish National Cancer Research Centre Lugano, 17 October 2017 Siegel, Ca Cancer J Clin,2017 Buzzoni, Eur Urol, 2015 -Aprox 15-20% of
More informationTesticular tumours are uncommon but constitute an
09010:Layout 1 3/18/10 9:26 PM Page E19 CONSENSUS GUIDELINE Canadian consensus guidelines for the management of testicular germ cell cancer Lori Wood, MD; * Christian Kollmannsberger, MD, FRCSC; Michael
More informationLos Angeles Radiological Society 62 nd Annual Midwinter Radiology Conference January 31, 2010
Los Angeles Radiological Society 62 nd Annual Midwinter Radiology Conference January 31, 2010 Self Assessment Module on Nuclear Medicine and PET/CT Case Review FDG PET/CT IN LYMPHOMA AND MELANOMA Submitted
More informationINTERACTIVE SESSION 2
INTERACTIVE SESSION 2 2 patients with lung metastases, with complete response after oncologic treatment - Clinical Case Presentation: Dr. Esther Casado Dr. Sergi Call - Expert Opinion: Dr. Raúl Embún Dr.
More informationTake Home Quiz 1 Please complete the quiz below prior to the session. Use the Multiple Primary and Histology Rules
Take Home Quiz 1 Please complete the quiz below prior to the session. Use the Multiple Primary and Histology Rules Case 1 72 year old white female presents with a nodular thyroid. This was biopsied in
More informationSurgery for recurrent brain metastases
Surgery for recurrent brain metastases Pr Philippe METELLUS Neurosurgeon, Clairval Hospital Center, Marseille 8th Annual Brain Metastases Research and Emerging Therapy Conference September 21st, 2018 Conflict
More informationX, Y and Z of Prostate Cancer
X, Y and Z of Prostate Cancer Dr Tony Michele Medical Oncologist Prostate cancer Epidemiology Current EUA (et al) guidelines on Advanced Prostate Cancer Current clinical management in specific scenarios
More informationAHSCT in Hodgkin lymphoma - indication and challenges. Bastian von Tresckow German Hodgkin Study Group Cologne University Hospital
AHSCT in Hodgkin lymphoma - indication and challenges Bastian von Tresckow German Hodgkin Study Group Cologne University Hospital AHSCT in Hodgkin Lymphoma The role of AHSCT in HL Mobilisation failure
More informationRadiological Manifestations of Metastatic Melanoma
Radiological Manifestations of Metastatic Melanoma Lia Hojman, Universidad de Chile Year VII Our patient: Clinical Presentation A 24 year old male. Former smoker. 8 months ago, he suffered a burn in his
More informationLIVER DIRECTED THERAPY IN UVEAL MELANOMA- THE SOUTHAMPTON EXPERIENCE
LIVER DIRECTED THERAPY IN UVEAL MELANOMA- THE SOUTHAMPTON EXPERIENCE DR IOANNIS KARYDIS ASSOCIATE PROFESSOR IN MEDICAL ONCOLOGY UNIVERSITY OF SOUTHAMPTON AND SOUTHAMPTON UNIVERSITY HOSPITAL UVEAL MELANOMA
More informationIndex. Surg Oncol Clin N Am 16 (2007) Note: Page numbers of article titles are in boldface type.
Surg Oncol Clin N Am 16 (2007) 465 469 Index Note: Page numbers of article titles are in boldface type. A Adjuvant therapy, preoperative for gastric cancer, staging and, 339 B Breast cancer, metabolic
More informationSurgical Oncology Perspective of Melanoma
Surgical Oncology Perspective of Melanoma Hans F. Schoellhammer, MD, FACS Assistant Clinical Professor Division of Surgical Oncology September 20, 2018 Nothing to disclose DISCLOSURE Discussion Objectives
More informationEAU Guidelines on Testicular Cancer
EAU Guidelines on Testicular Cancer P. Albers (Chair), W. Albrecht, F. Algaba, C. Bokemeyer, G. Cohn-Cedermark, K. Fizazi, A. Horwich, M.P. Laguna, N. Nicolai, J. Oldenburg Guidelines Associates: J.L.
More informationOVARIAN CANCER STATISTICS
bioprognos OncoOVARIAN Dx Non-invasive blood test useful to suggest a possible diagnosis in patients with suspected malignancy in the ovarians, reduce inappropriate diagnostic tests, days of hospitalization,
More informationSignificance of simultaneous determination of serum human chorionic gonadotropin (hcg) and hcg-b in testicular tumor patients
International Journal of Urology (2000) 7, 218 223 Original Article Significance of simultaneous determination of serum human chorionic gonadotropin (hcg) and hcg-b in testicular tumor patients SENJI HOSHI,
More informationFDG PET/CT STAGING OF LUNG CANCER. Dr Shakher Ramdave
FDG PET/CT STAGING OF LUNG CANCER Dr Shakher Ramdave FDG PET/CT STAGING OF LUNG CANCER FDG PET/CT is used in all patients with lung cancer who are considered for curative treatment to exclude occult disease.
More informationHematopoietic Cell Transplantation in the Treatment of Germ Cell Tumors (GCT)
Hematopoietic Cell Transplantation in the Treatment of Germ Cell Tumors (GCT) Policy Number: 8.01.35 Last Review: 7/2017 Origination: 7/2002 Next Review: 7/2018 Policy Blue Cross and Blue Shield of Kansas
More informationStaging Colorectal Cancer
Staging Colorectal Cancer CT is recommended as the initial staging scan for colorectal cancer to assess local extent of the disease and to look for metastases to the liver and/or lung Further imaging for
More informationData Supplement Table DS1: Pre-Treatment STM Assays to Evaluate Patients with CUP and Predict Chemotherapy Response
American Society of Clinical Oncology Clinical Practice Guideline on Uses of Serum Tumor Markers in Adult Males with Germ Cell Tumors Gilligan, et al. SUPPLEMENTAL TABLES DS1-DS13 Data Supplement Table
More informationEndobronchial Ultrasound in the Diagnosis & Staging of Lung Cancer
Endobronchial Ultrasound in the Diagnosis & Staging of Lung Cancer Dr Richard Booton PhD FRCP Lead Lung Cancer Clinician, Consultant Respiratory Physician & Speciality Director Manchester University NHS
More informationSarajevo (Bosnia Hercegivina) Monday June :30-16:15. PET/CT in Lymphoma
Sarajevo (Bosnia Hercegivina) Monday June 16 2013 15:30-16:15 PET/CT in Lymphoma FDG-avidity Staging (nodal & extra nodal) Response evaluation Early assessment during treatment / interim (ipet) Remission
More informationPET/CT in Gynaecological Cancers. Stroobants Sigrid, MD, PhD Departement of Nuclear Medicine University Hospital,Antwerp
PET/CT in Gynaecological Cancers Stroobants Sigrid, MD, PhD Departement of Nuclear Medicine University Hospital,Antwerp Cervix cancer Outline of this talk Initial staging Treatment monitoring/guidance
More informationFUJI study: Follow-Up of Jevtana in real life
Pharmacologie médicale Bordeaux PharmacoEpi CIC Bordeaux CIC1401 FUJI study: Follow-Up of Jevtana in real life French retrospective and protective multicenter observational study describing the survival,
More informationTwelve Years of Experience in the Management of Testicular Germ Cell Tumors at a Referral Center in Portugal
Elmer Press Original Article Twelve Years of Experience in the Management of Testicular Germ Cell Tumors at a Referral Center in Portugal Diana Valadares a, c, Filipe Nery a, Franklim Marques a, b Abstract
More informationLancet 2008; 372 : CDF. N Engl J Med Aug 28;349(9): J Clin Oncol May 15;19(10): Cancer Nov 1;113(9):2471-7
Tumour Group: UROLOGY Renal Palliative Sunitinib 1 st line therapy Lancet. 1999 Jan 2;353(9146):14-7. Pazopanib 1 st line therapy J Clin Oncol. 2010 28(06):1061-1068 Everolimus 2 nd or 3 rd line in adv./metas.rcc
More information